medroxyprogesterone acetate has been researched along with Soft Tissue Neoplasms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beaufort, F; Fereberger, W | 1 |
| Hayashi, K; Taniguchi, T; Toi, M; Tominaga, T | 1 |
| Atkins, JN; Bearden, JD; Case, LD; Cooper, MR; Cruz, JM; Jackson, DV; Muss, HB; O'Rourke, MA; Pavy, MD; Powell, BL | 1 |
| Baba, K; Fukuda, M; Higuchi, A; Ikeda, K; Matsuda, M; Matsuoka, Y; Nagao, K; Nishimura, R; Yamashita, H | 1 |
| Katoh, T; Kawahara, T; Kobayakawa, K; Takatsuka, Y; Tsumura, I | 1 |
| Inaii, H; Koyama, H; Noguchi, S; Yamamoto, H | 1 |
3 trial(s) available for medroxyprogesterone acetate and Soft Tissue Neoplasms
| Article | Year |
|---|---|
[The effect of combination treatment consisted of 5'-deoxy-5-fluorouridine and medroxyprogesterone acetate for recurrent breast cancer patient].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Drug Administration Schedule; Female; Floxuridine; Humans; Liver Neoplasms; Lung Neoplasms; Mastectomy, Radical; Medroxyprogesterone Acetate; Middle Aged; Soft Tissue Neoplasms | 1995 |
Tamoxifen versus high-dose oral medroxyprogesterone acetate as initial endocrine therapy for patients with metastatic breast cancer: a Piedmont Oncology Association study.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Drug Administration Schedule; Female; Humans; Liver Neoplasms; Medroxyprogesterone Acetate; Middle Aged; Prospective Studies; Regression Analysis; Soft Tissue Neoplasms; Survival Analysis; Tamoxifen | 1994 |
Predictive value of serum medroxyprogesterone acetate concentration for response in advanced or recurrent breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Bone Neoplasms; Breast Neoplasms; Dose-Response Relationship, Drug; Female; Forecasting; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Neoplasm Metastasis; Prognosis; Receptors, Estrogen; Soft Tissue Neoplasms; Treatment Outcome | 1997 |
3 other study(ies) available for medroxyprogesterone acetate and Soft Tissue Neoplasms
| Article | Year |
|---|---|
[High-dose gestagen therapy in breast cancer].
Topics: Adult; Bone Neoplasms; Breast Neoplasms; Castration; Dose-Response Relationship, Drug; Estrogen Antagonists; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Risk; Soft Tissue Neoplasms | 1983 |
[Successful treatment of disseminated breast cancer with combination therapy of 5'-deoxy-5'-fluorouridine (5'-DFUR), medroxyprogesterone acetate (MPA) and cyclophosphamide (CPA)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Papillary; Cyclophosphamide; Drug Administration Schedule; Female; Floxuridine; Humans; Liver Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Pleural Neoplasms; Soft Tissue Neoplasms | 1992 |
[Results of tamoxifen-medroxyprogesterone acetate sequential therapy in 22 patients with recurrent breast cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Humans; Lung Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Recurrence; Remission Induction; Soft Tissue Neoplasms; Tamoxifen; Weight Gain | 1989 |